← All diseases

Skin diseases

Incontinentia pigmenti (IP)

An inherited disease seen mostly in girls. A rash and patches appear on the skin that change over the years. The teeth, hair, eyes and brain can also be affected.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

This page is translated from the Turkish original.

This disease is followed through the “Skin diseases” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

The disease is caused by a change in the IKBKG gene. This gene protects cells against some harmful signals. In girls, some cells are healthy and some are affected. This is why skin changes appear in lines and swirls. The small blood vessels in the eyes and brain can also be affected.

Which symptoms can occur?

Skin symptoms change in stages over the years.

  • A blistering rash at birth or in the first months
  • Later, raised wart-like patches
  • Swirl-shaped grey-brown patches; they fade over time
  • Pale lines on the arms and legs in adults
  • Missing or small teeth
  • Hair loss and nail problems
  • Blood vessel problems in the retina and a risk of vision loss (in some people)
  • Seizures or developmental delay (sometimes)

How is it diagnosed?

The diagnosis is usually made from the typical skin findings. If needed, a genetic test of the IKBKG gene is done. The baby's eyes are examined often by an eye doctor in the first years. Because the disease can be mild, examining the mother is also recommended.

Treatment and care

The skin findings usually clear up on their own. The skin is kept clean and infection is prevented. Blood vessel problems in the retina can be treated with freezing or laser. Seizures and nervous system problems are followed by a child neurologist. A children's dentist is needed for dental problems; implants can be done in childhood. Developmental support and special education may be needed. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

Incontinentia pigmenti is passed on through X-linked dominant inheritance. In about 65 percent of patients, the gene change is new. For an affected mother, the chance of passing on the gene in each pregnancy is 1 in 2. Male babies who get this gene are usually lost before birth. This is why most patients are girls. Genetic counselling and testing options during pregnancy can be discussed.

Source: MedlinePlus Genetics: Incontinentia pigmenti · GeneReviews: Incontinentia Pigmenti · NORD: Incontinentia Pigmenti

Key facts

How is it inherited?
X-linked dominant
When does it usually start?
Newborn period
Gene(s) involved
IKBKG

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Guides related to this disease

  • Rare disease at school · Telling the school, medicines and emergency plan, inclusion and BEP, support education room, absences, LGS/YKS arrangements, peer bullying.

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about Incontinentia pigmenti

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.

See all studies on ClinicalTrials.gov · Joining clinical trials

Skin diseases: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:464 · ICD-11 LD27.00

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.